{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T14:55:28Z","timestamp":1793199328346,"version":"4.5.0"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2011,7,9]],"date-time":"2011-07-09T00:00:00Z","timestamp":1310169600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Radiol med"],"published-print":{"date-parts":[[2012,2]]},"DOI":"10.1007\/s11547-011-0710-9","type":"journal-article","created":{"date-parts":[[2011,7,9]],"date-time":"2011-07-09T02:14:30Z","timestamp":1310177670000},"page":"19-28","source":"Crossref","is-referenced-by-count":48,"title":["Role of cardiac MRI in evaluating patients with Anderson-Fabry disease: assessing cardiac effects of long-term enzyme replacement therapy","Ruolo della RM cardiaca nello studio dei pazienti con malattia di Anderson-Fabry: valutazione degli effetti cardiaci della terapia enzimatica sostitutiva a lungo termine"],"prefix":"10.1007","volume":"117","author":[{"given":"G.","family":"Messalli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Imbriaco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Avitabile","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Russo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Iodice","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Spinelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Dellegrottaglie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Cademartiri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Salvatore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Pisani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,7,9]]},"reference":[{"key":"710_CR1","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1136\/heart.89.8.819","volume":"89","author":"S.F. Nagueh","year":"2003","unstructured":"Nagueh SF (2003) Fabry disease. Heart 89:819\u2013820","journal-title":"Heart"},{"key":"710_CR2","doi-asserted-by":"crossref","first-page":"338","DOI":"10.7326\/0003-4819-138-4-200302180-00014","volume":"138","author":"R.J. Desnick","year":"2003","unstructured":"Desnick RJ, Brady R, Barranger J, Collins AJ (2003) Fabry disease, an under-recognized multisystemic disorder: expert recommendations for diagnosis, management, and enzyme replacement therapy. Ann Intern Med 138:338\u2013346","journal-title":"Ann Intern Med"},{"key":"710_CR3","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1203\/PDR.0b013e318183f132","volume":"64","author":"R.J. Hopkin","year":"2008","unstructured":"Hopkin RJ, Bissler J, Banikazemi M et al (2008) Characterization of Fabry disease in 352 paediatric patients in the Fabry Registry. Pediatr Res 64:550\u2013555","journal-title":"Pediatr Res"},{"key":"710_CR4","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1111\/j.1651-2227.2002.tb03104.x","volume":"91","author":"A. Linhart","year":"2002","unstructured":"Linhart A, Magage S, Palecek T et al (2002) Cardiac involvement in Fabry disease. Acta Paediatr Suppl 91:15\u201320","journal-title":"Acta Paediatr Suppl"},{"key":"710_CR5","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.ijcard.2008.03.007","volume":"130","author":"C. Kampmann","year":"2008","unstructured":"Kampmann C, Linhart A, Baehner F et al (2008) Onset and progression of the Anderson-Fabry disease related cardiomyopathy. Int J Cardiol 130:367\u2013373","journal-title":"Int J Cardiol"},{"key":"710_CR6","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1056\/NEJM200107053450102","volume":"345","author":"C.M. Eng","year":"2001","unstructured":"Eng CM, Guffon N, Wilcox WR et al (2001) Safety and efficacy of recombinant human alpha-galactosidase A replacement therapy in Fabry\u2019s disease. N Engl J Med 345:9\u201316","journal-title":"N Engl J Med"},{"key":"710_CR7","doi-asserted-by":"crossref","first-page":"2743","DOI":"10.1001\/jama.285.21.2743","volume":"285","author":"R. Schiffmann","year":"2001","unstructured":"Schiffmann R, Kopp JB, Austin HA III et al (2001) Enzyme replacement therapy in Fabry disease: a randomized controlled trial. JAMA 285:2743\u20132749","journal-title":"JAMA"},{"key":"710_CR8","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1086\/422366","volume":"75","author":"W.R. Wilcox","year":"2004","unstructured":"Wilcox WR, Banikazemi M, Guffon N et al (2004) Long-term safety and efficacy of enzyme replacement therapy for Fabry disease. Am J Hum Genet 75:65\u201374","journal-title":"Am J Hum Genet"},{"key":"710_CR9","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1161\/01.CIR.0000091253.71282.04","volume":"108","author":"F. Weidemann","year":"2003","unstructured":"Weidemann F, Breunig F, Beer M et al (2003) Improvement of cardiac function during enzyme replacement therapy in patients with Fabry disease: a prospective strain rate imaging study. Circulation 108:1299\u20131301","journal-title":"Circulation"},{"key":"710_CR10","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.jpeds.2004.01.051","volume":"144","author":"R.J. Desnick","year":"2004","unstructured":"Desnick RJ, Brady RO (2004) Fabry disease in childhood. J Pediatr 144:20\u201326","journal-title":"J Pediatr"},{"key":"710_CR11","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1038\/ncpneuro0407","volume":"3","author":"A.T. Moller","year":"2007","unstructured":"Moller AT, Jensen TS (2007) Neurological manifestations in Fabry\u2019s disease. Nat Clin Pract Neurol 3:95\u2013106","journal-title":"Nat Clin Pract Neurol"},{"key":"710_CR12","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1136\/hrt.2005.063818","volume":"93","author":"A. Linhart","year":"2007","unstructured":"Linhart A, Elliott PM (2007) The heart in Anderson-Fabry disease and other lysosomal storage disorders. Heart 93:528\u2013535","journal-title":"Heart"},{"key":"710_CR13","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1097\/01.ASN.0000016683.73778.78","volume":"13","author":"M. Branton","year":"2002","unstructured":"Branton M, Schiffmann R, Kopp JB (2002) Natural history and treatment of renal involvement in Fabry disease. J Am Soc Nephrol 13:139\u2013143","journal-title":"J Am Soc Nephrol"},{"key":"710_CR14","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1016\/S0140-6736(08)61589-5","volume":"372","author":"Y.A. Zarate","year":"2008","unstructured":"Zarate YA, Hopkin RJ (2008) Fabry\u2019s disease. Lancet 372:1427\u20131435","journal-title":"Lancet"},{"key":"710_CR15","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1136\/hrt.2006.113886","volume":"94","author":"A. Linhart","year":"2008","unstructured":"Linhart A (2008) Treatment of Anderson-Fabry disease. Heart 94:138\u2013139","journal-title":"Heart"},{"key":"710_CR16","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1056\/NEJM199102073240607","volume":"324","author":"W. Scheidt von","year":"1991","unstructured":"von Scheidt W, Eng CM, Fitzmaurice TF et al (1991) An atypical variant of Fabry\u2019s disease with manifestations confined to the myocardium. N Engl J Med 324:395\u2013399","journal-title":"N Engl J Med"},{"key":"710_CR17","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1093\/eurheartj\/ehi143","volume":"26","author":"F. Weidemann","year":"2005","unstructured":"Weidemann F, Breunig F, Beer M et al (2005) The variation of morphological and cardiac manifestation in Fabry disease: potential implications for the time course of the disease. Eur Heart J 26:1221\u20131227","journal-title":"Eur Heart J"},{"key":"710_CR18","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1681\/ASN.2006080816","volume":"18","author":"D.P. Germain","year":"2007","unstructured":"Germain DP, Waldek S, Banikazemi M et al (2007) Sustained long-term stabilization after 54 months of algasidase beta therapy in patients with Fabry disease. J Am Soc Nephrol 18:1547\u20131557","journal-title":"J Am Soc Nephrol"},{"key":"710_CR19","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1038\/sj.ki.5000208","volume":"69","author":"F. Breunig","year":"2006","unstructured":"Breunig F, Weidemann F, Strotmann J et al (2006) Clinical benefit of enzyme replacement therapy in Fabry disease. Kidney Int 69:1216\u20131221","journal-title":"Kidney Int"},{"key":"710_CR20","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1016\/j.amjcard.2005.11.087","volume":"97","author":"M. Beer","year":"2006","unstructured":"Beer M, Weidemann F, Breunig F et al (2006) Impact of enzyme replacement therapy on cardiac morphology and function and late enhancement in Fabry\u2019s cardiomiopathy. Am J Cardiol 97:1515\u20131518","journal-title":"Am J Cardiol"},{"key":"710_CR21","doi-asserted-by":"crossref","first-page":"W97","DOI":"10.2214\/AJR.08.1201","volume":"192","author":"F. Cobelli De","year":"2009","unstructured":"De Cobelli F, Esposito A, Belloni E et al (2009) Delayed-enhanced cardiac MRI for differentiation of Fabry\u2019s disease from symmetric hypertrophic cardiomiopathy. AJR Am J Roentgenol 192:W97\u2013W102","journal-title":"AJR Am J Roentgenol"},{"key":"710_CR22","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/0002-9149(83)90093-0","volume":"52","author":"C.B. Higgins","year":"1983","unstructured":"Higgins CB, Herfkens R, Lipton MJ et al (1983) Nuclear magnetic resonance imaging of acute myocardial infarction in dogs: alterations in magnetic relaxation times. Am J Cardiol 52:184\u2013188","journal-title":"Am J Cardiol"},{"key":"710_CR23","doi-asserted-by":"crossref","first-page":"850","DOI":"10.2214\/AJR.05.0442","volume":"188","author":"M. Imbriaco","year":"2007","unstructured":"Imbriaco M, Spinelli L, Cuocolo A et al (2007) MRI characterization of myocardial tissue in patients with Fabry\u2019s disease. AJR Am J Roentgenol 188:850\u2013853","journal-title":"AJR Am J Roentgenol"},{"key":"710_CR24","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1161\/CIRCULATIONAHA.108.794529","volume":"119","author":"F. Weidemann","year":"2009","unstructured":"Weidemann F, Niemann M, Breunig F et al (2009) Long-term effects of enzyme replacement therapy on Fabry cardiomyopathy: evidence for a better outcome with early treatment. Circulation 119:524\u2013529","journal-title":"Circulation"},{"key":"710_CR25","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1111\/j.1399-0004.2004.00284.x","volume":"66","author":"L. Spinelli","year":"2004","unstructured":"Spinelli L, Pisani A, Sabbatini M et al (2004) Enzyme replacement therapy with agalsidase beta improves cardiac involvement in Fabry\u2019s disease. Clin Genet 66:158\u2013165","journal-title":"Clin Genet"},{"key":"710_CR26","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1136\/hrt.2008.162800","volume":"95","author":"M. Imbriaco","year":"2009","unstructured":"Imbriaco M, Pisani A, Spinelli L et al (2009) Effects of enzyme replacement therapy in patients with Anderson-Fabry disease: a prospective long-term magnetic resonance imaging study. Heart 95:1103\u20131107","journal-title":"Heart"},{"key":"710_CR27","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1093\/ejechocard\/jen129","volume":"9","author":"T. Kovacevic-Preradovic","year":"2008","unstructured":"Kovacevic-Preradovic T, Zuber M, Attenhofer Jost CH et al (2008) Anderson-Fabry disease: long-term echocardiographic follow-up under enzyme replacement therapy. Eur J Echocardiogr 9:729\u2013735","journal-title":"Eur J Echocardiogr"}],"container-title":["La radiologia medica"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11547-011-0710-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11547-011-0710-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11547-011-0710-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,12]],"date-time":"2019-06-12T17:30:00Z","timestamp":1560360600000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11547-011-0710-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,7,9]]},"references-count":27,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,2]]}},"alternative-id":["710"],"URL":"https:\/\/doi.org\/10.1007\/s11547-011-0710-9","relation":{},"ISSN":["0033-8362","1826-6983"],"issn-type":[{"value":"0033-8362","type":"print"},{"value":"1826-6983","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,7,9]]}}}